Dermavant Sciences Email Format
Biotechnology ResearchCalifornia, United States51-200 Employees
Dermavant Sciences is a specialty biopharmaceutical company in the biotechnology research industry, based in Long Beach, California (3780 Kilroy Airport Way, Suite 250, 90806). The company focuses on developing prescription therapies for dermatologic diseases and has acquired compounds to establish a dermatology R&D pipeline aimed at first-in-class or best-in-class treatments, with the patient at the center of its work. VTAMA cream is part of its portfolio; Dermavant is developing VTAMA for atopic dermatitis, using the same dose and regimen that is FDA-approved for plaque psoriasis. Recent news in 2024 reports acquisitions involving Dermavant, including Organon's reported acquisition for $1.2 billion in October 2024 and a later report that Roivant Sciences acquired Dermavant. Dermavant maintains a website at dermavant.com.
1-888-653-2347 
support@leadiq.com 
